Phytotherapeutic BS012 and Its Active Component Ameliorate Allergic Asthma via Inhibition of Th2-Mediated Immune Response and Apoptosis.

Biomol Ther (Seoul) · 2024 · PMC11535288 · PMID 39370723

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Most metabolites showed an increasing trend after asthma induction, followed by a decrease after BS012 or Dexamethasone administration, whereas TG levels showed the opposite trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.